Modern Vaccines Adjuvants & Delivery Systems

4-6 July 2012, Eigtveds Pakhus, Copenhagen, Denmark

  • Increase font size
  • Default font size
  • Decrease font size


The drive for the new generation of vaccine therapies has precipitated a concurrent need for new and improved adjuvantation/delivery systems for these new vaccines. This new international conference will focus on updating the community on new adjuvant/delivery systems/technologies associated with developing modern vaccines strategies and vaccine research. There is now an urgent need for the development of these potent and safe adjuvants and delivery systems and MVADS 2012 will offer researchers a fresh forum to discuss this important topic in detail.

MVADS 2012 will be of interest to researchers/contributors from academic programs, industrial, governmental and regulatory groups.

Advisory Scientific Panel

Local Organisers:
Dennis Christensen (Statens Serum Institut, Copenhagen, Denmark)
Erik Lindblad (Brenntag Biosector, Copenhagen, Denmark)
Stein Lokstad (Brenntag Biosector, Copenhagen, Denmark)
Peter Andersen (Statens Serum Institut, Copenhagen, Denmark)

Alex Von Gabain (Intercell AG, Vienna, Austria)
Rob Lambkin-Williams (Retroscreen Virology Ltd, London, UK)
Kingston Mills (Trinity College, Dublin, Ireland)
Danuta Herzyk (Merck Research Laboratories, USA)
Derek O’Hagan (Novartis Vaccines, Cambridge, Massachusetts, USA)
Russell Mumper (University of North Carolina at Chapel Hill, USA)
Adriana Baz Morelli (CSL Ltd, Melbourne, Australia)
Virgil Schijns (Wageningen Unviversity, The Netherlands)
John Clements (Tulane University, New Orleans, Louisiana, USA)
Alan Shaw (Vedantra Corporation, Cambridge, Massachusetts, USA)
Gwyn Davies (St. George’s, University of London, UK)
Nathalie Garcon (GSK Biologicals, Rixensart, Belgium)
Greg Glenn (Novavax Inc., Maryland, USA)
Gary Ott (Dynavax Inc., San Diego, California, USA)
Heather Davis (Pfizer Vaccine Research, Ottawa, Canada)
Geert van den Bossche (Smart Vaccine Technologies, Seattle, Washington, USA)
Steve Reed (IDRI, Seattle, USA)
Frank Aldwell (University of Otago, Dunedin, New Zealand)
Stephane Ascarateil (SEPPIC, Paris, France)
Niranjan Sardesai (Inovio Pharmaceuticals, Blue Bell, Pennsylvania, USA)

Conference Scope

Scientific Sessions:

  • Mechanistic Interpretations
  • Delivery
  • Formulation & Design Modern Vaccines & Adjuvants
  • Safety
  • Regulation
  • Future Developments

MVADS 2012 Delegates

Login details will be supplied after you have registered for the event.

MVADS 2012 Sponsors

  • European Vaccine Initiative TRANSVAC
  • Dynavax Technologies
  • Eurocine
  • Wittycell
  • Isconova
  • European Vaccine Initiative EVI
  • Crossbeta Biosciences
  • Ichor Medical Systems
  • Cytos Biotechnology
  • Infectious Disease Research Institute
  • Sanofi Pasteur
  • Aldevron
  • CSL
  • Novartis Vaccines
  • ALK Abello
  • Immune Design
  • Intercell
  • Mucosis
  • ApoVax
  • European Adjuvant Advisory Committee
  • Seppic
  • Inovio Pharmaceuticals
  • Brenntag
  • Immune Solutions
  • Viscogel
  • Retroscreen Virology
  • European Vaccine Initiative PHARVAT
  • Statens Serum Institut
  • Pfizer

MVADS 2012 Downloads

MVADS 2012 Leaflet

MVADS 2012 Mailing List

E-mail Address
What is 1+4-2?